ArticlePakistan journal of medical sciences2026
Exploring the shared biomarkers between acute ischemia stroke and diabetes by transcriptome sequencing.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to identify shared genetic signatures and potential molecular mechanisms linking acute ischemic stroke (AIS) and diabetes by analyzing their transcriptomic profiles. We sought to characterize differentially expressed non-coding RNAs (ncRNAs) and mRNAs, elucidate their functional pathways, and construct regulatory networks to uncover cross-talk between these conditions. Methodology: Peripheral blood samples were collected from five patients with AIS and five patients with diabetes at the First Affiliated Hospital of Dali University between March 1, 2023 to September 31, 2023. Transcriptome sequencing was performed on these blood samples. Differentially expressed miRNAs (n=1,755), mRNAs (n=24,862), lncRNAs (n=7,387), and circRNAs (n=16,413) were identified (fold change >2, FDR <0.05) through comparative analysis of these groups. Functional enrichment was analyzed via GO and KEGG pathways. A ceRNA network integrating miRNA-mRNA-lncRNA-circRNA interactions was reconstructed using Cytoscape, with key regulators validated by degree centrality analysis. Results: Top dysregulated transcripts included hsa-miR-3614-5p (up) and hsa-miR-935 (down), mRNAs ENSG00000100985/ENSG00000154764 (MMP9/WNT7A), lncRNAs ENSG00000268734/ENSG00000272529, and circRNAs hsa-circ-0027541/hsa-circ-0024837. Pathway analysis revealed: (1) circRNAs modulated T-cell receptor signaling and NK cell cytotoxicity. (2)miRNA-target genes enriched in cancer/stem cell pathways (e.g., PI3K-Akt). (3) mRNAs implicated in inflammatory cascades (TNF/NF-κB). (4)The ceRNA network demonstrated 756 interactions centered on hsa-miR-619-5p, which coordinated mRNA-lncRNA-circRNA cross-talk. Conclusion: We identified convergent transcriptomic alterations in AIS-diabetes comorbidity, highlighting hsa-miR-619-5p as a hub regulator of immune-metabolic crosstalk. The integrated ceRNA network provides a mechanistic framework linking ncRNAs to inflammatory pathways, offering potential diagnostic biomarkers and therapeutic targets for dual disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.